long term side effects of glp 1 agonists Mapping the effectiveness and risks GLP-1 receptor The cardiovascular effects of GLP-1
Description
Branner, C

Other medications include Invokana (canagliflozin), Jardiance (empagliflozin), and Glyxambi (empagliflozin/linagliptin)

References Scheen AJ, Radermecker RP
Soy free

p-heterogeneity=0.90), and chronic kidney disease progression (HR 0.65
